Frequency of LATE neuropathologic change across the spectrum of Alzheimer’s disease neuropathology: combined data from 13 community-based or population-based autopsy cohorts

2022/06/13 by Peter T. Nelson, Carol Brayne, Margaret E. Flanagan +55 · 30 citations
Medicine · Environmental Science · Neuroscience · #Dementia and Cognitive Impairment Research #Health, Environment, Cognitive Aging #Functional Brain Connectivity Studies

paper · doi:10.1007/s00401-022-02444-1

Citations

• Neuropathological stageing of Alzheimer-related changes
• National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach
• Brain arteriolosclerosis

Cited by

• Comprehensive assessment of TDP-43 neuropathology data in the National Alzheimer’s Coordinating Center database
• Advance Care Planning Among Older Adults with Cognitive Impairment
• Cognitive and neuropsychological trajectories in patients with mixed neurodegenerative pathologies
• Controversial Past, Splendid Present, Unpredictable Future: A Brief Review of Alzheimer Disease History
• Tau pathology in epilepsy: emerging mechanisms and translational opportunities
• Integrity of Neuronal Size in the Entorhinal Cortex Is a Biological Substrate of Exceptional Cognitive Aging. [europepmc]
• Multiple gene variants linked to Alzheimer's-type clinical dementia via GWAS are also associated with non-Alzheimer's neuropathologic entities. [europepmc]
• LATE-NC staging in routine neuropathologic diagnosis: an update. [europepmc]
• TDP-43 Proteinopathy and Tauopathy: Do They Have Pathomechanistic Links? [europepmc]
• Repetitive head impacts and chronic traumatic encephalopathy are associated with TDP-43 inclusions and hippocampal sclerosis. [europepmc]
• Granulin loss of function in human mature brain organoids implicates astrocytes in TDP-43 pathology. [europepmc]
• Cognitive and Clinical Characteristics of Patients With Limbic-Predominant Age-Related TDP-43 Encephalopathy. [europepmc]
• Proteostasis failure exacerbates neuronal circuit dysfunction and sleep impairments in Alzheimer's disease. [europepmc]
• Brain proteomic analysis implicates actin filament processes and injury response in resilience to Alzheimer's disease. [europepmc]
• When Alzheimer's is LATE: Why Does it Matter? [europepmc]
• Different cohort, disparate results: Selection bias is a key factor in autopsy cohorts. [europepmc]
• NF-κB Pathway and Its Inhibitors: A Promising Frontier in the Management of Alzheimer's Disease. [europepmc]
• TDP-43 pathology is associated with increased tau burdens and seeding. [europepmc]
• Accelerating Alzheimer's therapeutic development: The past and future of clinical trials. [europepmc]
• Detection of TDP-43 seeding activity in the olfactory mucosa from patients with frontotemporal dementia. [europepmc]
• Alzheimer's disease and inflammatory biomarkers positively correlate in plasma in the UK-ADRC cohort. [europepmc]
• Cryptic splicing of stathmin-2 and UNC13A mRNAs is a pathological hallmark of TDP-43-associated Alzheimer's disease. [europepmc]
• Controversial Past, Splendid Present, Unpredictable Future: A Brief Review of Alzheimer Disease History. [europepmc]
• Fluid biomarkers for amyotrophic lateral sclerosis: a review. [europepmc]
• A fluid biomarker reveals loss of TDP-43 splicing repression in presymptomatic ALS-FTD. [europepmc]
• Is Alzheimer disease a disease? [europepmc]
• Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS. [europepmc]
• GWAS of multiple neuropathology endophenotypes identifies new risk loci and provides insights into the genetic risk of dementia. [europepmc]
• Clinical criteria for limbic-predominant age-related TDP-43 encephalopathy. [europepmc]
• Role of tau versus TDP-43 pathology on medial temporal lobe atrophy in aging and Alzheimer's disease. [europepmc]